Search Results 391-400 of 18424 for Prostate cancer
The FDA recently expanded the indication of lutetium Lu 177 vipivotide tetraxetan for PSMA-positive metastatic castration-resistant prostate cancer, ...
Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.
DEAR MAYO CLINIC: My father, 71, was diagnosed with early-stage prostate cancer last month. He is worried about the side effects of surgery and radiation, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.